Elanco Animal Health Inc

ELAN 10-K · FY 2025

ELAN FY 2025 request

Playground key active
Request URL /api/financials?ticker=ELAN&year=2025&quarter=4&full_year_mode=true
waiting 0 ms
Pick an endpoint and run the request.
curl

Income Statement

Income Statement
Metric FY 2025 FY 2024 YoY
Revenue 4,715 4,439 +6.2%
Show Product Lines breakouts
Cattle 1,125 1,007 +11.7%
Contract Manufacturing and Other 53 46 +15.2%
Farm Animal: 2,362 2,250 +5.0%
Pet Health 2,300 2,143 +7.3%
Poultry 858 796 +7.8%
Swine 379 366 +3.6%
Show Business Segments breakouts
Reportable Segment 4,715 4,439 +6.2%
Show Geography breakouts
Non Us 2,481 2,403 +3.2%
US 2,234 2,036 +9.7%
Cost of Revenue 2,122 2,003 +5.9%
Show Business Segments breakouts
Reportable Segment 2,122 2,003 +5.9%
Gross Profit 2,593 2,436 +6.4%
Show Business Segments breakouts
Reportable Segment 2,593 2,436 +6.4%
Research & Development 368 344 +7.0%
Show Business Segments breakouts
Reportable Segment 368 344 +7.0%
Selling, General & Administrative 1,430 1,314 +8.8%
Amortization Of Intangible Assets 543 527 +3.0%
Restructuring Costs And Asset Impairment Charges 237 150 +58.0%
Interest Expense Operating 220 235 -6.4%
Show Business Segments breakouts
Reportable Segment 220 235 -6.4%
Other Operating Income Expense Net 19 18 +5.6%
Show Business Segments breakouts
Reportable Segment 19 18 +5.6%
Income Before Taxes -224 488 -145.9%
Income Tax Expense (Benefit) 8 150 -94.7%
Show Business Segments breakouts
Reportable Segment 8 150 -94.7%
Net Income -232 338 -168.6%
Show Business Segments breakouts
Reportable Segment -232 338 -168.6%
Show Equity Components breakouts
Retained Earnings -232 338 -168.6%
EPS (Basic) -0.47 0.68 -169.1%
EPS (Diluted) -0.47 0.68 -169.1%
Wtd Avg Shares (Basic) 496.4 494 +0.5%
Wtd Avg Shares (Diluted) 496.4 497.3 -0.2%
Total Costs & Expenses (FY)
Show Business Segments breakouts
Reportable Segment 2,045 2,061 -0.8%
Sales & Marketing (FY)
Show Business Segments breakouts
Reportable Segment 923 809 +14.1%
General & Administrative (FY)
Show Business Segments breakouts
Reportable Segment 507 505 +0.4%
Interest Income 43 31 +38.7%
Show Derivative Risk breakouts
Foreign Exchange Contract · Designated As Hedging Instrument 45 31 +45.2%
Comprehensive Income 398 -167 +338.3%
Other Comprehensive Income 630 -505 +224.8%
Show Equity Components breakouts
Accumulated Defined Benefit Plans Adjustment 32 2 +1500.0%
Accumulated Gain Loss Net Cash Flow Hedge Parent -49 -20 -145.0%
Accumulated Other Comprehensive Income 630 -505 +224.8%
Accumulated Translation Adjustment 647 -487 +232.9%
Marketing And Advertising Expense 314 236 +33.1%

Balance Sheet

Balance Sheet
Metric FY 2025 FY 2024 YoY
Current Assets
Cash & Cash Equivalents 545 468 +16.5%
Accounts Receivable 873 805 +8.4%
Show Product Lines breakouts
Product 107 90 +18.9%
Other Receivables Net Current 67 81 -17.3%
Inventory 1,737 1,574 +10.4%
Prepaid Expenses & Other Current Assets 236 287 -17.8%
Total Current Assets 3,458 3,215 +7.6%
Non-Current Assets
Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization 1,409 993 +41.9%
Show Geography breakouts
DE 250 230 +8.7%
Other foreign countries 187 153 +22.2%
US 972 610 +59.3%
Goodwill 4,779 4,414 +8.3%
Intangible Assets Net Excluding Goodwill 3,408 3,681 -7.4%
Other Non-Current Assets 304 311 -2.3%
Total Assets 13,358 12,614 +5.9%
Operating Lease Right-of-Use Assets 116 122 -4.9%
Intangible Assets 3,400 3,390 +0.3%
Show Finite Lived Intangible Assets By Major Class breakouts
Computer Software Intangible Asset 94 116 -19.0%
Marketing Related Intangible Assets 3,288 3,251 +1.1%
Other Intangible Assets 18 23 -21.7%
Current Liabilities
Accounts Payable 368 296 +24.3%
Employee Related Liabilities Current 206 177 +16.4%
Deferred Revenue (Current) 416 332 +25.3%
Long Term Debt And Capital Lease Obligations Current 74 44 +68.2%
Other Liabilities Current 533 466 +14.4%
Total Current Liabilities 1,597 1,315 +21.4%
Non-Current Liabilities
Long Term Debt And Capital Lease Obligations 3,943 4,277 -7.8%
Sale Of Future Revenue Liability Noncurrent 304
Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent 158 175 -9.7%
Show Retirement Plan Type breakouts
Pension Plans Defined Benefit 152 167 -9.0%
Deferred Tax Liabilities 382 449 -14.9%
Other Non-Current Liabilities 427 302 +41.4%
Total Liabilities 6,811 6,518 +4.5%
Long-Term Debt 3,762 4,321 -12.9%
Operating Lease Liabilities 86 92 -6.5%
Stockholders' Equity
Additional Paid-In Capital 8,870 8,817 +0.6%
Retained Earnings -2,182 -1,950 -11.9%
Accumulated Other Comprehensive Income -141 -771 +81.7%
Total Stockholders' Equity 6,547 6,096 +7.4%
Show Equity Components breakouts
Accumulated Defined Benefit Plans Adjustment 90 58 +55.2%
Accumulated Gain Loss Net Cash Flow Hedge Parent -12 37 -132.4%
Accumulated Other Comprehensive Income -141 -771 +81.7%
Accumulated Translation Adjustment -219 -866 +74.7%
Additional Paid In Capital 8,870 8,817 +0.6%
Retained Earnings -2,182 -1,950 -11.9%
Total Liabilities & Equity 13,358 12,614 +5.9%

Cash Flow Statement

Cash Flow Statement
Metric FY 2025 FY 2024 YoY
Operating Activities
Depreciation & Amortization 680 662 +2.7%
Deferred Income Taxes -134 -112 -19.6%
Stock-Based Compensation 68 55 +23.6%
Asset Impairment Charges Including Inventory Write Down 71 81 -12.3%
Purchase And Sale Agreement Sold Portion Of Royalty Revenue -19
Show Counterparty Name breakouts
Blackstone Life Sciences And Blackstone Credit & Insurance -19
Purchase And Sale Agreement Interest On Liability For Sale Of Future Revenue 33
Show Counterparty Name breakouts
Blackstone Life Sciences And Blackstone Credit & Insurance 33
Other Operating Activities Cash Flow Statement -6 3 -300.0%
Increase Decrease In Accounts And Other Receivables -12 12 -200.0%
Change in Inventory -57 44 -229.5%
Increase Decrease In Other Operating Assets 21 11 +90.9%
Increase Decrease In Accounts Payable And Other Operating Liabilities 147 82 +79.3%
Net Cash from Operations 560 541 +3.5%
Investing Activities
Capital Expenditures -276 -147 -87.8%
Proceeds From Divestiture Of Businesses 9 1,360 -99.3%
Other Investing Activities -12 -14 +14.3%
Net Cash from Investing -279 1,158 -124.1%
Financing Activities
Proceeds From Lines Of Credit (FY)
Show Debt Instrument breakouts
Revolving Credit Facility 125 50 +150.0%
Securitization Facility 125 170 -26.5%
Securitization Facility · Secured Debt 125
Show Credit Facility breakouts
Revolving Credit Facility · Line Of Credit 125
Repayments Of Lines Of Credit (FY)
Show Debt Instrument breakouts
Revolving Credit Facility -125 -250 +50.0%
Securitization Facility -125 -195 +35.9%
Securitization Facility · Secured Debt -125
Show Credit Facility breakouts
Revolving Credit Facility · Line Of Credit -125
Proceeds From Issuance Of Senior Long Term Debt 2,106 350 +501.7%
Repayments Of Senior Debt -2,669 -1,600 -66.8%
Proceeds From Sale Of Future Revenue 290
Proceeds From Payments For Other Financing Activities -2 -17 +88.2%
Net Cash from Financing -275 -1,492 +81.6%
Supplemental
Income Taxes Paid 225 140 +60.7%
Interest Paid 206 296 -30.4%
Other Cash Flow
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 71 -91 +178.0%
Net Change in Cash 77 116 -33.6%
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 545 468 +16.5%

Values in millions USD. Source: SEC EDGAR 10-K filing.

This table is rendered from the same JSON returned by /api/financials.

Get API Key